The Center for Business Complexity and Global Leadership
And the Center for Entrepreneurship
The Sawyer Business School
73 Tremont Street, 9th Floor
Welcomes Michael Greeley, General Partner of Flybridge Capital Partners
For a conversation about complexity, entrepreneurship, and venture capital today
While big hits like Facebook and Google are vivid reminders of the promise of entrepreneurship and venture capital the number and size of IPOs over the past several years suggests a more somber reality. Does the recent contraction and shakeout of the venture capital industry in the face of the world's largest public offering suggest that the landscape for innovation and entrepreneurship is changing? Or is the innovation landscape simply retooling for a new wave of ground breaking opportunities for entrepreneurs as a variety of fields including nanotechnology, clean energy, smart phones and mobile technology, cloud computing, network science and social media, etc. pave the way for a new convergence to exploit?
Free and open to the Suffolk Community and our Partners
Please RSVP firstname.lastname@example.org
FLYBRIDGE CAPITAL PARTNERS
Michael's principle investment focus area is the application of "Big Data" platforms across a number of industry verticals. Additionally, Michael is excited about the convergence of healthcare and information technologies, as well as robotics and human-machine interface technologies.
Michael currently represents the firm on the boards of BlueTarp Financial, MicroCHIPs, PolyRemedy, Predictive Biosciences, SpringLeaf Therapeutics, T2 Biosystems, TARIS Biomedical, and VidSys and led the firm's investment in lighterliving, Magen BioSciences and Protein Forest.
Michael founded IDG Ventures Atlantic in 2001 before it transitioned to Flybridge Capital Partners in 2008. Michael served on the board of International Data Group, the flagship Limited Partner for the IDG Ventures global network of funds.
Previously, Michael was with Polaris Venture Partners, where he focused on both early-stage and later-stage financings for emerging growth companies. Before Polaris, Michael served as Senior Vice President and Founding Partner of GCC Investments, a $200 million private equity fund. Prior to GCC Investments, Michael was a Vice President and one of the early professionals at Wasserstein Perella & Co., an international merchant bank with a $1.0 billion private equity fund. Additionally, Michael was a member of the Mergers and Acquisitions Department of Morgan Stanley & Co. and worked in the Leveraged Buyout Group of Credit Suisse First Boston.
In previous positions, Michael has served on the Boards of a number of public and private companies including FleetCor Technologies (NYSE: FLT), Global TeleSystems Group (NASDAQ: GTSG), El Sitio International (NASDAQ: LCTO), MotherNature.com (NASDAQ: MTHR), Crescent Communications (acquired by Clear Channel), and American Capital Access.
Michael currently serves on the board of the National Venture Capital Association, as Chair of the Entrepreneurship Committee of the Massachusetts Information Collaborative, as co-Founder of the 12x12 program, on the board of the New England Investors' Committee of Capital Innovation, and was recently appointed a Venture Capital Consultant for the Defense Venture Catalyst Initiative (DeVenCI), an initiative for the Department of Defense. He also serves on the investment committee of the Partners Innovation Fund, is a member of the Executive Business Advisory Council for Mass General Hospital for Children, and a trustee and on the investment committee of the Massachusetts Eye and Ear Infirmary. He previously served as Chairman and President of the New England Venture Capital Association.
"In order for business methodologies to incorporate innovation, they have to make peace with uncertainty. Uncertainty is a place holder for things to be created. It is like the incorporation of the zero in mathematics. Who could have imagined that adding nothingness would launch science into the modern world?", Hamid Benbrahim, 2010